Skip to main content

Peer Review reports

From: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

Original Submission
8 Jan 2022 Submitted Original manuscript
9 Feb 2022 Reviewed Reviewer Report
26 Feb 2022 Reviewed Reviewer Report
7 Mar 2022 Author responded Author comments - Jie chen
Resubmission - Version 2
7 Mar 2022 Submitted Manuscript version 2
14 Mar 2022 Author responded Author comments - Jie chen
Resubmission - Version 3
14 Mar 2022 Submitted Manuscript version 3
15 Mar 2022 Author responded Author comments - Jie chen
Resubmission - Version 4
15 Mar 2022 Submitted Manuscript version 4
27 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report
18 Apr 2022 Author responded Author comments - Jie chen
Resubmission - Version 5
18 Apr 2022 Submitted Manuscript version 5
4 May 2022 Reviewed Reviewer Report
8 May 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
9 May 2022 Editorially accepted
13 May 2022 Article published 10.1186/s12885-022-09654-6

You can find further information about peer review here.

Back to article page